Associated Papers
Current Classification of Canine Muscular Dystrophies and Identification of New Variants.
Shelton GD et al.
Genes, 2023
37628610 (PubMed )
Supplement: genes-14-01557-s001.zip › Table_S1._List_of_the_unique_coding_variants_of_each_dog.xlsx › Brittany_case_2
Prime Editing for Human Gene Therapy: Where Are We Now?
Godbout K et al.
Cells, 2023
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy.
Happi Mbakam C et al.
International Journal of Molecular Sciences, 2022
Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.
Okubo M et al.
Orphanet Journal of Rare Diseases, 2017
28859693 (PubMed )
Supplement: 13023_2017_703_MOESM1_ESM.pdf
Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM et al.
Journal of Molecular Medicine (berlin, Germany), 2002
Select a paper to view details